Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1511797

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1511797

Herbal Medicine Market Size, Share & Trends Analysis Report By Intervention (Ayurveda, Traditional Chinese Medicine), By Product Form (Tablet/Capsules, Powder), By Source, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 137 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Herbal Medicine Market Growth & Trends:

The global herbal medicine market size is anticipated to reach USD 328.72 billion by 2030 and is projected to grow at a CAGR of 20.91% from 2024 to 2030, according to a new report by Grand View Research, Inc. There is a key shift towards healthier lifestyles, with individuals increasingly prioritizing their well-being and seeking natural alternatives to conventional healthcare. This inclination towards holistic wellness is accompanied by a growing preference for herbal remedies, perceived as gentler and safer options compared to synthetic drugs.

Consumers are increasingly seeking plant-based solutions due to concerns over the adverse effects of synthetic drugs, aligning with a broader shift towards holistic wellness and preventive healthcare. According to the World Health Organization (WHO), approximately 4 billion people i.e., 80% of the world's population use botanicals for some aspect of primary health care.

The advancements in extraction and formulation technologies have enhanced the efficacy and quality of botanical, making them more appealing to a broader audience. As scientific research continues to validate the benefits of remedies, consumer trust in these products is on the rise. Cultural and traditional practices also play a significant role, with the rich history of botanicals contributing to its growing popularity. With an expanding product range and distribution channels, including online platforms, these alternative therapy is becoming increasingly accessible and mainstream, driving further market growth.

There is an increasing demand for evidence-based medicine across all healthcare sectors, including botanicals. Clinical trials play a crucial role in advancing our understanding of traditional medicines and validating their efficacy, safety, and potential therapeutic benefits. In March 2024, 4 plant-based supplements, Yerba Buena, Ulasimang Bato, Tsaang Gubat, and Ampalaya, have passed clinical trials by the Institute of Herbal Medicine-National Institute of Health of University of the Philippines. These supplements have been proven to be effective in treating elevated relieving body pains, uric acid levels, lowering sugar levels in diabetics, and providing anti-colic relief for loose bowel movements and gallstones.

Herbal Medicine Market Report Highlights:

  • Based on intervention. the ayurveda segment led the market with the largest revenue share of 27.7% in 2023, owing to its increasing awareness of the benefits of ayurvedic products and the growing adoption and acceptance of Ayurveda
  • The tablet/capsules segment held the market with the largest revenue share of 46.10% in 2023. This growth is attributable to the ease of consumption, precise dosing, and portability offered by this product form
  • Based on source, the roots segment led the market with the largest revenue share of 38.07% in 2023, owing to their traditional use in herbal remedies and various formulations
  • Based on distribution channel, the direct sales segment led the market with the largest revenue share of 67.62% in 2023, due to its benefits of personalized recommendations and customization of product as per need
Show more
Product Code: GVR-4-68040-293-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Intervention
    • 1.2.2. Product form
    • 1.2.3. Source
    • 1.2.4. Distribution Channel
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Intervention
    • 2.2.2. Product form
    • 2.2.3. Source
    • 2.2.4. Distribution channel
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Herbal Medicine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising health concerns
      • 3.2.1.2. Growing consumer preference for natural remedies
      • 3.2.1.3. Technological advancements in extraction and formulation of herbal medicines
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Regulatory challenges
      • 3.2.2.2. Quality control issues
  • 3.3. Herbal medicine Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Pricing Analysis
    • 3.3.3. Pricing Analysis

Chapter 4. Herbal Medicine Market: Intervention Estimates & Trend Analysis

  • 4.1. Intervention Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Herbal Medicine Market by Intervention Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Ayurveda
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Apitherapy
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Injections Bach Flower Therapy
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Naturopathic Medicine
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Traditional Chinese Medicine
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Traditional Korean Medicine
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Traditional Japanese Medicine
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.8. Traditional Mangolian Medicine
      • 4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.9. Traditional Tibetan Medicine
      • 4.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.10. Zang Fu Theory
      • 4.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Herbal Medicine Market: Product Form Estimates & Trend Analysis

  • 5.1. Product Form Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Herbal Medicine Market by Product Form Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Powder
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Liquid/gel
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Tablets/Capsules
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Herbal Medicine Market: Source Estimates & Trend Analysis

  • 6.1. Source Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Herbal Medicine Market by Source Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Barks
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Leaves
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Roots
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Herbal Medicine Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Distribution Channel Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Herbal Medicine Market by Distribution Channel Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Direct Sales
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 7.4.2. E- sales
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Herbal Medicine Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key Country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key Country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key Country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key Country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key Country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key Country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key Country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key Country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key Country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key Country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key Country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key Country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key Country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key Country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key Country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Key Country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key Country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key Country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key Country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. Sheng Chang Pharmaceutical Company
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Intervention benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Nordic Nutraceuticals
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Intervention benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Herb Pharma
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Intervention benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. AYUSH Ayurvedic Pte Ltd.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Intervention benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Herbal Hills
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Intervention benchmarking
    • 9.3.9. LKK Health Products Group Limited
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Intervention benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. International Chinese Body Care Houses
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Intervention benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. KindCare Medical Center
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Intervention benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Pascoe Natural Medicine
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Intervention benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Bionorica SE
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Intervention benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Ming Chen Clinic
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Intervention benchmarking
      • 9.3.14.4. Strategic initiatives
    • 9.3.15. The Center for Natural and Integrative Medicine
      • 9.3.15.1. Company overview
      • 9.3.15.2. Financial performance
      • 9.3.15.3. Intervention benchmarking
      • 9.3.15.4. Strategic initiatives
    • 9.3.16. Sinomedica
      • 9.3.16.1. Company overview
      • 9.3.16.2. Financial performance
      • 9.3.16.3. Intervention benchmarking
      • 9.3.16.4. Strategic initiatives

Chapter 10. Conclusion and Analyst Perspective

Show more
Product Code: GVR-4-68040-293-0

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America Herbal Medicine Market, by Country, 2018 - 2030 (USD Million)
  • Table 4 North America Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 5 North America Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 6 North America Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 7 North America Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 8 U.S. Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 9 U.S. Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 10 U.S. Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 11 U.S. Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 12 Canada Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 13 Canada Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 14 Canada Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 15 Canada Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Europe Herbal Medicine Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 18 Europe Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 19 Europe Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 20 Europe Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 Germany Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 22 Germany Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 23 Germany Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 24 Germany Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 UK Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 26 UK Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 27 UK Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 28 UK Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 France Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 30 France Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 31 France Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 32 France Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Italy Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 34 Italy Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 35 Italy Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 36 Italy Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Spain Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 38 Spain Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 39 Spain Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 40 Spain Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Denmark Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 42 Denmark Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 43 Denmark Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 44 Denmark Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Sweden Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 46 Sweden Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 47 Sweden Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 48 Sweden Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 49 Norway Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 50 Norway Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 51 Norway Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 52 Norway Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Herbal Medicine Market, by Country, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 Japan Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 59 Japan Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 60 Japan Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 61 Japan Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 China Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 63 China Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 64 China Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 65 China Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 India Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 67 India Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 68 India Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 69 India Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Australia Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 71 Australia Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 72 Australia Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 73 Australia Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74 Thailand Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 75 Thailand Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 76 Thailand Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 77 Thailand Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 78 South Korea Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 79 South Korea Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 80 South Korea Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 81 South Korea Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 Latin America Herbal Medicine Market, by Country, 2018 - 2030 (USD Million)
  • Table 83 Latin America Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 84 Latin America Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 85 Latin America Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 86 Latin America Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Brazil Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 88 Brazil Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 89 Brazil Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 90 Brazil Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 Mexico Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 92 Mexico Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 93 Mexico Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 94 Mexico Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 95 Argentina Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 96 Argentina Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 97 Argentina Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 98 Argentina Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 99 MEA Herbal Medicine Market, by Country, 2018 - 2030 (USD Million)
  • Table 100 MEA Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 101 MEA Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 102 MEA Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 103 MEA Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 104 South Africa Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 105 South Africa Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 106 South Africa Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 107 South Africa Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 112 UAE Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 113 UAE Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 114 UAE Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 115 UAE Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Herbal Medicine Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Herbal Medicine Market, by Product Form, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Herbal Medicine Market, by Source, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Herbal Medicine Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Herbal medicine market: market outlook
  • Fig. 9 Herbal medicine competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Herbal medicine market driver impact
  • Fig. 15 Herbal medicine market restraint impact
  • Fig. 16 Herbal medicine market strategic initiatives analysis
  • Fig. 17 Herbal medicine market: Intervention movement analysis
  • Fig. 18 Herbal medicine market: Intervention outlook and key takeaways
  • Fig. 19 Ayurveda market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Apitherapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Bach flower therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Naturopathic medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Traditional Chinese medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Traditional Korean medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Traditional Japanese medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Traditional Mongolian medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Traditional Tibetan medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Zang Fu Theory market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Herbal medicine market: Product Form movement analysis
  • Fig. 30 Herbal medicine market: Product Form outlook and key takeaways
  • Fig. 31 Powder market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Liquid/Gel market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Tablets/ Capsules market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Herbal medicine market: Source movement analysis
  • Fig. 36 Herbal medicine market: Source outlook and key takeaways
  • Fig. 37 Barks market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Leaves market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Roots market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Market share of key market players- Herbal medicine market
  • Fig. 42 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 43 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 44 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 45 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 46 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 47 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 48 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 49 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 50 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 51 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 52 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 53 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 54 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 55 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 56 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 57 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 58 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 59 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 60 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 61 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 62 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 63 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 64 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
  • Fig. 65 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 66 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 67 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 68 UAE market size, & forecasts and trend analysis, 2018 to 2030(USD Million)
  • Fig. 69 Kuwait market size, & forecasts and trend analysis, 2018 to 2030(USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!